Home›Companies›Healthcare›Aseko

Aseko, Inc.

Through Glytec, provides insulin management software to healthcare providers.

No website or LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Sep 25, 2026·Suggest an edit

About Aseko

Aseko is a private company based in Atlanta, Georgia. It has reported $85,943,692 raised in 19 offerings on Form D since July 2009.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 23, 2024Sep 25, 2026$9,999,996fully sold17$588KEquity, Securities on exerciseRule 506(b)Form D ↗
Oct 26, 2022Nov 18, 2022amended Aug 14, 2023$19,352,750target not set22$879KDebt, Options, Convertible Promissory NotesRule 506(b)Form D/A ↗3 earlier filings
May 14, 2020May 29, 2020$5,999,999of $12.0M target27$222KEquity, Options, Securities on exercise, Series J Convertible Preferred Stock and Warrants to Purchase Series J Preferred StockRule 506(b)Form D ↗
Jul 16, 2019Oct 15, 2019$6,411,522of $17.1M target21$305KEquity, Options, Securities on exercise, Series I Convertible Preferred Stock and WarrantsRule 506(b)Form D ↗
Jul 16, 2019Jul 31, 2019$1,375,000of $2.0M target13$105KDebt, Subordinated Promissory NotesRule 506(b)Form D ↗
Mar 30, 2018Apr 9, 2018$4,703,605of $5.0M target23$204KDebt, Securities on exerciseRule 506(b)Form D ↗
May 25, 2017Jun 7, 2017$4,062,500fully sold33$123KEquity, OptionsRule 506(b)Form D ↗
Mar 3, 2016Mar 21, 2016$4,999,865of $5.0M target36$138KEquity, OptionsRule 506(b)Form D ↗
Feb 18, 2015Feb 27, 2015amended Aug 20, 2015$5,100,000of $5.3M target14$364KEquity, OptionsRule 506(b)Form D/A ↗1 earlier filing
Aug 1, 2014Aug 14, 2014$2,500,000fully sold10$250KEquity, OptionsRule 506(b)Form D ↗
Nov 7, 2013Nov 13, 2013$2,971,815of $3.0M target19$156KEquity, OptionsRule 506(b)Form D ↗
Jul 2, 2013Jul 15, 2013$3,499,997of $3.5M target19$184KEquity, Options06Form D ↗
Nov 2, 2012Nov 16, 2012$2,525,000fully sold34$74,265Equity, Options06Form D ↗
Nov 2, 2012Nov 16, 2012$1,475,000fully sold1$1.4MEquity, Options06Form D ↗
Sep 7, 2011Sep 16, 2011$8,273,078of $10.0M target2$4.1MEquity06Form D ↗
May 26, 2011Jun 9, 2011$2,000,000fully sold1$2.0MDebt, Options06Form D ↗
May 16, 2011May 27, 2011$462,150fully sold1$462KEquity06Form D ↗
Dec 31, 2010Jan 13, 2011$100,000fully sold5$20,000Options, Securities on exercise06Form D ↗
Jul 3, 2009Jul 13, 2009$131,415of $9.5M target15$8,761Equity06Form D ↗
Total, 19 offerings$85,943,692

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aseko's Form D filed Sep 25, 2026.

BB
Bruce Bode
Director
DD
Deborah Dean
Director
PC
Patrick Cua
Executive officer and director
AM

Earlier filings also listed Stephen Wallack (executive officer, last listed Aug 2023), Edmond Furlong (executive officer and director, last listed Aug 2023), Daniel Frank (director, last listed Aug 2023), John Beneke (executive officer, last listed Oct 2019), Robert Leonard (executive officer and director, last listed Jul 2019), Paul Fulchino (director, last listed Jul 2019), Megan Pietropaolo (executive officer, last listed Jul 2019) and Lynn Vogel (director, last listed Jul 2019).

Sources

  1. SECAseko, Inc. Form D/A, filed Jul 13, 2023
  2. SECAseko, Inc. Form D/A, filed Jun 8, 2023
  3. SECAseko, Inc. Form D, filed Nov 18, 2022
  4. SECAseko, Inc. Form D, filed Feb 27, 2015
  5. SECAseko, Inc. filing history
  6. InvestorPalladium Capital: Glytec debt financing
  7. CompanyAseko Technology home page